PTC Therapeutics
Email page Email Page  Print Page Print Page  Contact Us   Text Size
A  A  A
 Ataluren
 PTC299
 Neurofibromatosis Type
 2 Clinical Trial Overview
 Kaposi's Sarcoma
 Clinical Trial Overview
 Metastatic Breast Cancer
 Clinical Trial Overview
 Metastatic Breast Cancer
 Trial Sites
 Advanced Solid Tumors
 Clinical Trial Overview
Metastatic Breast Cancer Clinical Trial Sites

Indiana University Simon Cancer Center
Indianapolis, Indiana 46202

Principal Investigator: Bryan P. Schneider, M.D.
Contact: Anita Rush-Taylor
Phone: 317-278-6797
Email: arushtay@iupui.edu


New York University Clinical Cancer Center
New York, NY 10016

Principal Investigator:
Amy D. Tiersten, M.D.
Contact: Verula escobia
Phone: 212-263-4414
Email: verula.escobia@nyumc.org

Additional information about this PTC299 clinical trial can be found at www.clinicaltrials.gov or by contacting Patient and Professional Advocacy at (866) 282-5873 (toll free in the United States), (908) 912-9256 or PatientInfo@ptcbio.com.